Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand

Kareem Bedeir, Robert P. Giugliano, Basel Ramlawi

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


One in every five strokes is due to atrial fibrillation. Anticoagulation is the evidence-based practice for stroke risk reduction in patients with atrial fibrillation. After decades of using warfarin, the recent years have seen an exponential increase in the available oral anticoagulants. An understanding of where things stand regarding indications, relative safety and efficacy as well as the limitations of each available choice is crucial.

Original languageEnglish (US)
Pages (from-to)615-619
Number of pages5
JournalInternational Journal of Cardiology
StatePublished - Nov 1 2016


  • Atrial fibrillation
  • Bleeding prevention
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand'. Together they form a unique fingerprint.

Cite this